Skip to main content
Premium Trial:

Request an Annual Quote

Gene Patents, Again

A US Senate panel is considering legislation that would expand the array of subject matter that is eligible to be patented — including, possibly, genes, as GenomeWeb has reported.

The Senate Judiciary Subcommittee on Intellectual Property held hearings this week and is to hold another hearing next week to discuss draft legislation on patent eligibility introduced by Senators Chris Coons (D-Del.) and Thom Tillis (R-NC).

If the new amendment becomes law, Futurism writes that biotech and pharmaceutical companies could be able to patent human genes. This, the Washington Post notes, would reverse US Supreme Court rulings handed down in a series of three cases — Association for Molecular Pathology v. Myriad Genetics Inc.Mayo Collaborative Services v. Prometheus Laboratories Inc., and Alice Corp. v. CLS Bank International — that said products of nature, laws of nature, and abstract ideas cannot be patented.

As GenomeWeb notes, proponents of the draft bill say it would reform patent law and bring it in line with European, Japanese, and Chinese patent laws, while critics argue it would slow medical advances and prevent competition.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.